Podcast appearances and mentions of hannah kuchler

The runaway success of diabetes and weight-loss drugs Ozempic and Wegovy have turned their maker, Novo Nordisk, into a juggernaut. Last year the Danish drugmaker claimed the title of Europe's most valuable company. But the development of these drugs was a long, uphill battle.The FT's global pharmaceutical editor Hannah Kuchler explains how the company's unique ownership structure played a critical role in the company's achievements and looks at the challenges ahead. Clips from CNBC, CBS, Reuters- - - - - - - - - - - - - - - - - - - - - - - - - - Subscribe and listen to Untold: The Retreat on Apple Podcasts, Spotify or wherever you get your podcasts.- - - - - - - - - - - - - - - - - - - - - - - - - - For further reading:FT Person of the Year: Lars Fruergaard Jørgensen of Novo NordiskHow anti-obesity drugs built the world's largest charitable foundationObesity drugs: broadly good for investors, with some stricturesCovid-19 vaccine winners suffer reversal of fortune- - - - - - - - - - - - - - - - - - - - - - - - - - On X, follow Hannah Kuchler (@hannahkuchler) and Michela Tindera (@mtindera07), or follow Michela on LinkedIn for updates about the show and more. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

This week we speak with Shirin Neshat, one of the most famous contemporary artists from Iran, about the protests in her home country. Shirin's work focuses on the lives and struggles of Iranian women. The protests have been raging for a month, which, as Shirin says, makes them the longest-running demonstrations since the 1979 Islamic revolution. We talk about what they mean, why this time they're different, and her art, some of which has been recently projected on buildings in London and Los Angeles. Then, we hear about a new trend in drug research. Scientists can now grow entire human mini-organs in labs. Could that lead to a world without animal testing? The FT's Clive Cookson and Hannah Kuchler join us to discuss.-------Want to stay in touch? We love hearing from you. Email us at ftweekendpodcast@ft.com. We're on Twitter @ftweekendpod, and Lilah is on Instagram and Twitter @lilahrap.-------Links and mentions from the episode:– Shirin Neshat is on Instagram at @shirin__neshat– Shirin's video installation Turbulent, 1998: https://www.youtube.com/watch?v=VCAssCuOGls– Some photos of Shirin's Women of Allah series: https://www.matronsandmistresses.com/articles/2021/4/29/shirin-neshat – Baraye, by Shervin Hajipour https://www.youtube.com/watch?v=TPyHuCZzsVA – An interview with Shirin in the FT from September 2021: https://on.ft.com/3zVaVk8– How science is getting closer to a world without animal testing, by Clive, Hannah and Joe Miller: https://on.ft.com/3SPlFuA– Hannah is on Twitter @hannahkuchler, and Clive is on Twitter @clivecookson-------Special offers for FT Weekend listeners, from 50% off a digital subscription to a $1/£1/€1 trial can be found here: http://ft.com/weekendpodcast-------Original music by Metaphor Music. Mixing and sound design by Breen Turner and Sam Giovinco Hosted on Acast. See acast.com/privacy for more information.

This week we speak with Shirin Neshat, one of the most famous contemporary artists from Iran, about the protests in her home country. Shirin's work focuses on the lives and struggles of Iranian women. The protests have been raging for a month, which, as Shirin says, makes them the longest-running demonstrations since the 1979 Islamic revolution. We talk about what they mean, why this time they're different, and her art, some of which has been recently projected on buildings in London and Los Angeles. Then, we hear about a new trend in drug research. Scientists can now grow entire human mini-organs in labs. Could that lead to a world without animal testing? The FT's Clive Cookson and Hannah Kuchler join us to discuss.-------Want to stay in touch? We love hearing from you. Email us at ftweekendpodcast@ft.com. We're on Twitter @ftweekendpod, and Lilah is on Instagram and Twitter @lilahrap.-------Links and mentions from the episode:– Shirin Neshat is on Instagram at @shirin__neshat– Shirin's video installation Turbulent, 1998: https://www.youtube.com/watch?v=VCAssCuOGls– Some photos of Shirin's Women of Allah series: https://www.matronsandmistresses.com/articles/2021/4/29/shirin-neshat – Baraye, by Shervin Hajipour https://www.youtube.com/watch?v=TPyHuCZzsVA – An interview with Shirin in the FT from September 2021: https://on.ft.com/3zVaVk8– How science is getting closer to a world without animal testing, by Clive, Hannah and Joe Miller: https://on.ft.com/3SPlFuA– Hannah is on Twitter @hannahkuchler, and Clive is on Twitter @clivecookson-------Special offers for FT Weekend listeners, from 50% off a digital subscription to a $1/£1/€1 trial can be found here: http://ft.com/weekendpodcast-------Original music by Metaphor Music. Mixing and sound design by Breen Turner and Sam Giovinco Hosted on Acast. See acast.com/privacy for more information.

This week, we hear about a new 'miracle' weight-loss drug called Wegovy. It has unprecedented clinical results and endorsements from celebrities such as Queen Latifah. But critics say it deals with the symptom but not the cause. Then, we're joined by Lauren Indvik, the FT's fashion editor. She explains how to efficiently pinpoint your personal style, and build a wardrobe that saves money, time and carbon emissions. Plus, she answers listener questions.--------------Want to stay in touch? We love hearing from you. We're on Twitter @ftweekendpod, and Lilah is on Instagram and Twitter @lilahrap.--------------Links and mentions from the episode: – Hannah Kuchler's piece, ‘A new ‘miracle' weight loss drug really works – raising huge questions': https://on.ft.com/3vpSBQh – Lauren Indvik's dispatch from the Paris runway, ‘A return to decadence at Paris couture': https://on.ft.com/3BoXNrl – Hannah Kuchler is on Twitter @hannahkuchler. Lauren is on Twitter @laureni. —-----------Special offers for FT Weekend listeners, from 50% off a digital subscription to a $1/£1/€1 trial can be found here: http://ft.com/weekendpodcastWant to join us at the FT Weekend festival in London on September 3rd? Buy a ticket at ft.com/ftwf. And here's a special £20 off promo code, specifically for FT Weekend listeners: FTWFxPodcast22--------------Original music by Metaphor Music. Mixing and sound design by Breen Turner and Sam Giovinco.Read a transcript of this episode on FT.com See acast.com/privacy for privacy and opt-out information.

This week, we hear about a new 'miracle' weight-loss drug called Wegovy. It has unprecedented clinical results and endorsements from celebrities such as Queen Latifah. But critics say it deals with the symptom but not the cause. Then, we're joined by Lauren Indvik, the FT's fashion editor. She explains how to efficiently pinpoint your personal style, and build a wardrobe that saves money, time and carbon emissions. Plus, she answers listener questions.--------------Want to stay in touch? We love hearing from you. We're on Twitter @ftweekendpod, and Lilah is on Instagram and Twitter @lilahrap.--------------Links and mentions from the episode: – Hannah Kuchler's piece, ‘A new ‘miracle' weight loss drug really works – raising huge questions': https://on.ft.com/3vpSBQh – Lauren Indvik's dispatch from the Paris runway, ‘A return to decadence at Paris couture': https://on.ft.com/3BoXNrl – Hannah Kuchler is on Twitter @hannahkuchler. Lauren is on Twitter @laureni. —-----------Special offers for FT Weekend listeners, from 50% off a digital subscription to a $1/£1/€1 trial can be found here: http://ft.com/weekendpodcastWant to join us at the FT Weekend festival in London on September 3rd? Buy a ticket at ft.com/ftwf. And here's a special £20 off promo code, specifically for FT Weekend listeners: FTWFxPodcast22--------------Original music by Metaphor Music. Mixing and sound design by Breen Turner and Sam Giovinco.Read a transcript of this episode on FT.com See acast.com/privacy for privacy and opt-out information.

Even though the COVID-19 vaccines were born of publicly-funded research, our privatized medical system has left them to for-profit companies like Pfizer to distribute, giving these private companies massive power in a time of great need. On the show this week to dive into the ways Pfizer has used and abuse its power is Financial Times global pharmaceutical correspondent Hannah Kuchler.

Read a transcript of this episode on FT.comhttps://www.ft.com/content/b6aa92ea-4a07-4423-acbe-deacad5313a5Twitter co-founder Jack Dorsey stepped down as the company's chief executive on Monday, and an activist investor has called on commodities giant Glencore to spin off its thermal coal business. Plus, the FT's global pharmaceutical correspondent, Hannah Kuchler, explains how Pfizer came to dominate the market for Covid jabs and what the concerns are about the company's market power. Activist calls on Glencore to spin off coal assetshttps://www.ft.com/content/6f5a8c43-76d4-4843-a15e-47bc767ec6d8Jack Dorsey resigns as Twitter chief executivehttps://www.ft.com/content/bf45fd08-51d1-41bb-82cd-b3157a5da055The inside story of the Pfizer vaccine: ‘a once-in-an-epoch windfall'https://www.ft.com/content/0cea5e3f-d4c4-4ee2-961a-3aa150f388ecThe FT News Briefing is produced by Fiona Symon and Marc Filippino. The show's editor is Jess Smith. Additional help by Peter Barber, Gavin Kallmann and Michael Bruning. The show's theme song is by Metaphor Music. The FT's global head of audio is Cheryl Brumley. See acast.com/privacy for privacy and opt-out information.

How did one family become associated with an epidemic of drug addiction that has caused the death of almost half a million people?In this episode, award-winning writer and author of Empire of Pain, Patrick Radden Keefe speaks to Hannah Kuchler, the FT's global pharmaceutical correspondent about how he uncovered fresh material on the Sacklers and discovered a modern parable of greed, corruption and cynical philanthropy.To buy the book click here: https://www.primrosehillbooks.com/product/empire-of-pain-the-secret-history-of-the-sackler-dynasty-patrick-keefe-subscribers/ Support this show http://supporter.acast.com/intelligencesquared. See acast.com/privacy for privacy and opt-out information.

More than 300 million doses of Covid 19 vaccines have been administered - that's nearly three times the number of official Covid cases. But, the novelist William Gibson once said: the future is already here, it's just not very evenly distributed and that's certainly true for Covid 19 vaccines. Some countries are the haves, and others the have nots. So, where do we go from here if we are going to bring this pandemic to an end? That's the question Tim Harford asks this week's panel of guests: Gian Gandhi of UNICEF, Hannah Kuchler from the Financial Times and Prashant Yadav from Center for Global Development. Producers: Sandra Kanthal and Beth Sagar-Fenton Listener questions can be sent to: vaccine@bbc.co.uk

Could a piece of high-tech cloth keep Covid-19 patients out of hospital and allow them to be monitored at home? The FT’s pharma and biotech correspondent, Hannah Kuchler, reports on the wearable technology changing healthcare during the pandemic, and examines what it means for the future of patient care.Hosted by John Thornhill, innovation editor at the Financial Times. Produced by Liam Nolan. Sound Design by Breen Turner and Louise Burton. Aimee Keane is the editor and the executive producer is Cheryl Brumley. Original music by Metaphor Music. See acast.com/privacy for privacy and opt-out information.

The Boston-based biotech eschewed a traditional approach to vaccine development, instead pitching its use of mRNA technology to investors. That pitch paid off this year as the company stands to be one of the first to bring a Covid-19 vaccine to market. Hannah Kuchler, the FT’s US pharma and biotech correspondent, reports on Moderna’s race to find an immunisation for the novel coronavirus. The FT is making key coronavirus coverage free to read for everyone. Go to ft.com/coronavirusfree to read the latest.Read more here: Moderna’s Covid vaccine offers vindication of its unconventional approachReview clips: Yahoo Finance, CNBC See acast.com/privacy for privacy and opt-out information.

It has been about six months since coronavirus shook the west. We’ll talk to the FT’s Gillian Tett and Hannah Kuchler about how the pandemic has changed the global economy and the medical industry community in such a short amount of time. See acast.com/privacy for privacy and opt-out information.

How a drug company made millions pushing an opioid painkiller up to 100x stronger than heroin, as many on Wall Street looked the other way. FRONTLINE filmmaker Tom Jennings and Financial Times reporter Hannah Kuchler discuss their new investigation of Insys Therapeutics — from a jaw-dropping interview with a former sales director who admits to bribing doctors to prescribe the highly addictive drug Subsys, to how Wall Street propelled Insys’ success even as questions emerged about its practices, to what role drug companies’ pursuit of profits has played in the opioid crisis: “I think that it's really interesting just how people are able to disconnect their actions from the consequences, especially in business,” Kuchler says. With federal prosecutors using laws designed to catch mob bosses, Insys would ultimately become the first pharmaceutical company to have its top executives sentenced to prison time in connection with the opioid epidemic. For more on Insys’ spectacular rise and fall — and its consequences — watch the documentary Opioids, Inc. from FRONTLINE and the FT, and read our in-depth joint reporting — also available at ft.com/insys.

How a drug company made millions pushing an opioid painkiller up to 100x stronger than heroin, as many on Wall Street looked the other way. FRONTLINE filmmaker Tom Jennings and Financial Times reporter Hannah Kuchler discuss their new investigation of Insys Therapeutics — from a jaw-dropping interview with a former sales director who admits to bribing doctors to prescribe the highly addictive drug Subsys, to how Wall Street propelled Insys’ success even as questions emerged about its practices, to what role drug companies’ pursuit of profits hasplayed in the opioid crisis: “I think that it's really interesting just how people are able to disconnect their actions from the consequences, especially in business,” Kuchler says. With federal prosecutors using laws designed to catch mob bosses, Insys would ultimately become the first pharmaceutical company to have its top executives sentenced to prison time in connection with the opioid epidemic. For more on Insys’ spectacular rise and fall — and its consequences — watch the documentary Opioids, Inc. from FRONTLINE and the FT, and read our in-depth joint reporting — also available at  ft.com/insys.

Executives from drugmaker Insys were the first from the pharmaceutical sector to be handed prison time for their role in America’s opioid epidemic earlier this year. The FT and the PBS series Frontline have investigated why the warning signs around the company were ignored for so long. FT pharmaceutical correspondent Hannah Kuchler tells Marc Filippino what they uncovered.Read the story at ft.com/insys.The PBS Frontline documentary, Opioids, Inc. is available for streaming online at PBS.org beginning Friday June 19, and will premiere on American PBS stations on Tuesday, June 23. For more information visit: https://www.pbs.org/wgbh/frontline/film/opioids-inc/. See acast.com/privacy for privacy and opt-out information.

New York is in the middle of a boutique fitness boom. Manhattanites can choose from a wide range of Insta-friendly - but pricey - gyms, offering everything from spin classes to workouts in a giant fridge. But what options are available in poorer neighbourhoods? In this episode, Darren Dodd discusses a tale of two cities with Hannah Kuchler, the FT’s US pharma correspondent.This podcast is supported by Novo Nordisk. To read more FT health coverage, visit FT.com/reports See acast.com/privacy for privacy and opt-out information.

US senator Bernie Sanders declared victory in the New Hampshire Democratic presidential primary on Tuesday night, ride-sharing service Lyft disappointed investors who were looking for signs of an end to the losses, and electric scooter companies operating in Germany are braced for a setback on the streets as authorities push for a regulatory crackdown. Plus, the FT’s Hannah Kuchler explains why investors are bidding up companies that are working to alleviate the effects of the coronavirus. See acast.com/privacy for privacy and opt-out information.

A powerful rebound in Intel’s data centre division drove a stronger than expected recovery in the final quarter of 2019, former Wells Fargo chief executive John Stumpf has agreed to pay $17.5m as part of a settlement with US regulators over the bank’s fake accounts scandal, and the European Central Bank begins its first strategic review in 16 years. Plus, the founder of the opioid maker Insys has been sentenced to five-and-a-half years in prison. The FT’s Hannah Kuchler explains what this means for other US pharmaceutical executives. See acast.com/privacy for privacy and opt-out information.

UK prime minister Boris Johnson threatens to call an October 14 general election if rebel Tory MPs join forces with Labour today, Germany’s export-dependent economy is suffering from a Brexit shock as a potential recession looms and the long-running merger talks between Allen & Overy and O’Melveny & Myers collapse. Plus, the FT’s Hannah Kuchler goes into the history of Verily, the health organisation spun out of Google’s secretive research facility. See acast.com/privacy for privacy and opt-out information.

President Donald Trump issues an executive order to collect all information in US government databases about who is an American citizen, Boeing says the head of its 737 programme will retire at the end of this year and we take a look at China’s economy ahead of the release of its second-quarter growth figures. Plus, Hannah Kuchler explains why some drugmakers are braced for an opioid crisis reckoning. See acast.com/privacy for privacy and opt-out information.

Hannah Kuchler talks to American cardiologist Eric Topol about his book Deep Medicine, which looks at the potential for artificial intelligence technology to help free up doctors to spend more time with their patients. See acast.com/privacy for privacy and opt-out information.

The success of the Brexit party in European elections ramps up pressure on Britain to leave the EU without a deal, Aviva is preparing a big shake-up of its UK business and Disney’s live action remake of the 1992 animated classic ‘Aladdin’ grabbed the top spot at the US box office over the holiday weekend. Plus, the FT’s pharma correspondent Hannah Kuchler reports that technology companies are betting that their insights into human behaviour can help opioid addicts recover. See acast.com/privacy for privacy and opt-out information.

The heightened trade war with China hands US stocks their biggest one-day drop in months, Uber shares lose more than a tenth of their value in the ride-hailing app’s second day of trading and a California court orders Bayer to pay more than $2bn in damages to a pair of cancer patients who claimed that their non-Hodgkin’s lymphoma was caused by the German group’s weedkiller, RoundUp. Plus, the FT’s pharmaceutical and biotech reporter, Hannah Kuchler, explains why a lawsuit backed by 44 US states alleges that some generic drugmakers, including Teva and Pfizer, have been fixing prices of more than 100 drugs. See acast.com/privacy for privacy and opt-out information.

Tech Values Julia Hobsbawm kicks off Series 2 of The Human and Machine with a look at how we value tech itself in society. Includes interviews with Hannah Kuchler, Technology Correspondent, Financial Times; Aron Ain, CEO of Kronos Incorporated and author of Work Inspired; plus we throw a Spotlight on a social good company: QDOOZ with its Strategy chief Tony Manwaring. Click here to subscribe on iTunes  Click here to subscribe on Acast Follow updates on Twitter @technoshabbat #humanandmachine

Tesla chief executive Elon Musk announces a price cut to $35,000 for the Model 3, retailer Gap reveals plans to split itself in two, HBO’s Richard Plepler quits in the wake of the AT&T takeover, and Israel’s attorney general intends to indict prime minister Benjamin Netanyahu on corruption charges. Then the FT’s Hannah Kuchler tells us about the US biotech startup that’s raising money for research into ending genetic diseases. See acast.com/privacy for privacy and opt-out information.

Sociologist Jonathan Lusthaus spent seven years talking to cyber criminals. He tells Hannah Kuchler what he discovered about the extent of their involvement with organised crime and what he thinks it would take to persuade them to put their talents to better use. His book: Industry of Anonymity: Inside the Business of Cybercrime, was published by Harvard University Press. See acast.com/privacy for privacy and opt-out information.

Hannah Kuchler talks to American social scientist and cyber security expert Andrea Little Limbago about the worrying lack of agreement among governments on how best to promote the beneficial aspects of the internet. See acast.com/privacy for privacy and opt-out information.

YouTube video bloggers broadcast their lives on the Google-owned platform in the hope of attracting followers, fame, and money, say Hannah Kuchler and Emma Jacobs. They are overwhelmingly young and can build multimillion dollar businesses, but stars are few and even for them, popularity can bring huge stresses and pressures See acast.com/privacy for privacy and opt-out information.

On Tuesday Facebook exposed the first disinformation campaign designed to influence the upcoming US midterm elections. The FT's San Francisco correspondent Hannah Kuchler explains the scope of the campaign, and what details we have about who might be behind it. Read more here. See acast.com/privacy for privacy and opt-out information.

Digital distraction lurks everywhere. Google and Apple have taken steps to address smartphone addiction, but critics say the big tech groups have not regulated enough to cure hardcore addicts, say Tim Bradshaw and Hannah Kuchler. What's the solution to Silicon Valley's struggle between responsibility and revenue? Produced by Molly Mintz See acast.com/privacy for privacy and opt-out information.

Chip Paucek, Founder of digital campus company 2U, chats about the future of higher education with Hannah Kuchler from the Financial Times.

South-east Asia is one of Facebook's fastest growing markets, but the social media company is under fire over the spread of false news and incitements to violence in the region. The FT's John Reed and Hannah Kuchler report. See acast.com/privacy for privacy and opt-out information.

Russia's use of the social network to interfere in the US election has raised serious questions over Facebook's model, say Hannah Kuchler and Barney Jopson. Action to try to control fake news and political ads has done little to ease pressure on the company See acast.com/privacy for privacy and opt-out information.

Last month, a man used Facebook’s live video feature to confess to a murder, shortly after videos were uploaded that showed him announcing his intent and committing the act. Facebook broke down the timeline of this series of videos, revealing that they had suspended the person’s account in approximately 2 hours or less, saying “we need to do better.” But what is a reasonable expectation for the public, when it comes to people who use live video to gain attention for their violent acts, against themselves or others? Heather Merrick, community experience manager at group video chat service Airtime, joins the show to discuss. Plus: How allowing users to switch video chats from public to private, and back, complicates community management efforts What happened when Tumblr switched replies off on their platform Unethical behavior and the implications of getting caught Big Quotes “It’s nice to have that option, [to flag content simply because you don’t like it,] because it’s essentially, ‘We want you to feel comfortable.’ It’s the comfort option. ‘Maybe I just don’t feel like seeing this slightly icky image that isn’t really offending me deeply but isn’t really my vibe today. I don’t want to see that.’ You can hide it, and I think that’s useful. You don’t necessarily want to be getting someone else in trouble. I think some moderation tools can feel really serious, like if you’re blocking someone on various platforms. … Are you notifying the person that you’ve blocked them? If so, that’s kind of like a big step in that relationship, right?” -@heatheremerrick “Ambiguity is not usually the friend of community.” -@patrickokeefe “In the world of engineering, it’s so hard to nail down an exact date for when something’s going to happen because something unexpected will always arise, so I completely understand the need to have somewhat ambiguous timelines. I think if you were to say, ‘Hey, we’re embarking on this gigantic project and we guarantee it will be live by July 3rd,’ you’re going to let people down. … There’s somewhere in between, where you can sort of be like, ‘Hey, this is going to take us a few months and we promise we’ll give you updates along the way, so stay tuned. Two weeks from today, we’ll let you know.’ That kind of thing. It could be considered overcommunicating.” -@heatheremerrick About Heather Merrick Heather Merrick is an experienced community and support team manager. She’s worked for startups since 2008, including Tumblr, Stripe, Automattic (makers of WordPress.com) and Airtime, where she is currently community experience manager. Related Links Heather’s website Airtime, a group video service, where Heather is community experience manager “19-Year-Old Commits Suicide on Justin.tv” by Liz Gannes for Gigaom Twitch, a video game livestreaming service and community “Man Wanted to Facebook Murder Video Kills Himself, Police Say” by Hannah Kuchler for Financial Times, about the man who Facebook to announce his intent to murder someone, commit the act and then confess to it “Community Standards and Reporting” by Justin Osofsky, VP, global operations at Facebook, covering Facebook’s response to the event “Genius: $56.9 Million in Funding, 6+ Years to Add a Report Abuse Button” by Patrick, about Genius’ poor approach to community abuse Google Forms, which allows you to create surveys Periscope, a live video service where some Airtime users had previously connected “Your Replies Are on the Way, Tumblr” by Tumblr staff, covering the platform’s response when users were unhappy that they removed replies from their service Elizabeth Tobey, formerly Heather’s boss at Tumblr “Unroll.me is Sorry-Not-Sorry it Sold Email Data to Uber” by Jon Fingas for Engadget “One Billion Yahoo! Accounts Still for Sale, Despite Hacking Indictments” by Vindu Goel for The New York Times “Uber’s CEO Plays With Fire” by Mike Isaac for The New York Times “The Price of Nice Nails” by Sarah Maslin Nir for The New York Times Heather on Twitter Transcript View transcript on our website Your Thoughts If you have any thoughts on this episode that you’d like to share, please leave me a comment, send me an email or a tweet. If you enjoy the show, we would be grateful if you spread the word. Thank you for listening to Community Signal.

Mark Zuckerberg plans to tour the US following Donald Trump’s election as president. The Facebook founder said, “we are at a turning point in history” and spoke of the need to “find a way to change the game so that it works for everyone”. Chris Nuttall discusses the reasons for the tour and how other tech leaders are reacting to the Trump victory with Hannah Kuchler, the FT's San Francisco correspondent. See acast.com/privacy for privacy and opt-out information.

The Obama White House hasn't always had the easiest of relationships with the Kremlin during his eight-year tenure, and it doesn't look like it's about to get any cosier. And that's because President Obama has ordered US intelligence agencies to investigate all cyber attacks and alleged foreign interventions in US presidential elections - and he wants the results on his desk before he leaves the White House on January twentieth. It was of course alleged during the campaign that Russia was amongst those states looking to interfere in the election. Hannah Kuchler who covers cyber security for the Financial Times in San Francisco explains more. It's a country the size of a continent, but the potential sale of private land of more than 1 per cent of the Australian landmass has caused controversy. We'll hear why the purchase of the Kidman estate is causing such concern from Danny Samson live in Melbourne. Plus, the Malaysian delegation shopping in London for data-savvy professionals to boost its growing tech sector. And you've heard of L'oreal, Maybeline and Max Factor - but what about Suzie Beauty? We'll hear from Nairobi about the Kenyan make-up artists looking to join the big name brands on a shelf near you soon. How can we eat healthily, sustainably and yet still tastily? It's the conundrum governments, scientists and the industry amongst others are pondering at a fringe event at the Nobel Prize awards in Oslo. We'll hear from two of the delegates. The BBC's Fergus Nicoll will be joined throughout the programme by Danny Samson, Professor of Management at the University of Melbourne, in Australia. (Picture: President Barack Obama pauses as he speaks at MacDill Air Force Base Credit: AP Photo/Carolyn Kaster)

Tech groups and digital media stars are taking the initiative in challenging terrorist propaganda from groups like Isis, say Madhumita Murgia and Hannah Kuchler. They are using 'counter speech' to fight extremists' propaganda with their own chosen tools of persuasion — such as YouTube, Facebook, Twitter and Google See acast.com/privacy for privacy and opt-out information.

The Facebook-owned messaging app has been blocked and unblocked several times in recent months in Latin America's biggest economy. The company was not pleased and nor were its customers. Ravi Mattu asks the FT's Samantha Pearson in São Paulo and Hannah Kuchler in San Francisco what's behind the disruption. See acast.com/privacy for privacy and opt-out information.

The Rise of the Robots author Martin Ford stops by to discuss his pessimistic outlook on the future of automation after winning the FT-McKinsey Business Book of the Year Award this week. Then, San Francisco correspondent Hannah Kuchler breaks down how Facebook is turning to user data to power its artificial intelligence products. Finally, US retail sales are lagging in advance of the critical holiday shopping season, even as total consumer spending grows. FT correspondents Lindsay Whipp and Eric Platt offer some explanations. Music: "Plain Loafer" by Kevin MacLeod. See acast.com/privacy for privacy and opt-out information.

Media correspondent Shannon Bond asks San Francisco correspondent Hannah Kuchler and management editor Andrew Hill what Jack Dorsey's dual CEO roles at the messaging company and payments group Square mean for both companies' future. Producer Aimee Keane reports from the annual #FTPubQuiz in New York. Finally, Cardiff Garcia previews one more excerpt from his long-form Alphachatterbox interview with chief economics commentator Martin Wolf. See acast.com/privacy for privacy and opt-out information.

In this episode of Alphachat, host Cardiff Garcia and FT media correspondent Shannon Bond assess the winners and losers of a disappointing debate among Republican candidates for the White House. Then, San Francisco correspondent Hannah Kuchler calls in to discuss the growing success of YouTube video stars. Finally, Cardiff and fellow Alphavillian Matt Klein reflect on the much anticipated rate decision from the Federal Reserve board. See acast.com/privacy for privacy and opt-out information.

The Silicon Valley company's plan to spin off its $24bn stake in Alibaba suffered a second major setback this week when the IRS, the US tax authority, said it had serious concerns about deals similar to the one proposed by Yahoo. Aimee Keane speaks with San Francisco correspondent Hannah Kuchler about the authority's statement and what effect it could have on the potential spin-off. See acast.com/privacy for privacy and opt-out information.

Jeff Bezos, Amazon's chief executive, has been forced on the defensive over stinging allegations about the retail company's management style. Matthew Vincent talks to Hannah Kuchler, FT correspondent in San Francisco, about the allegations and the differences in work culture between Seattle and Silicon Valley. See acast.com/privacy for privacy and opt-out information.

Are hackers winning the battle for cyber security? FT West Coast editor Richard Waters speaks with San Francisco correspondent Hannah Kuchler and investigations correspondent Kara Scannell to discuss how banks, companies and governments are finding ways to marshal their defences. Find more reporting on the topic at FT.com/cyberinsecurity. Music: "Guttersnipe" by Jim Rooster. See acast.com/privacy for privacy and opt-out information.

Snapchat has lured Millennials by creating a new type of social media app, but can it figure out a way to make money out of them? Ravi Mattu discusses its attempt to convince advertisers that it can offer them a way to reach the next generation of consumers with Hannah Kuchler and Shannon Bond. See acast.com/privacy for privacy and opt-out information.

Github, the online forum for software developers, has been hit by a powerful cyber attack that security experts believe originated in China. FT technology editor Ravi Mattu discusses the attack with Hannah Kuchler, the FT's correspondent in San Francisco and Charles Clover, the FT's correspondent in Beijing. See acast.com/privacy for privacy and opt-out information.

Google is doubling the number of US cities that will receive its super fast broadband service and is calling for better co-operation from local authorities to help improve internet speeds in their areas. Ravi Mattu talks to Hannah Kuchler about why Google is so keen to spread its superfast network. See acast.com/privacy for privacy and opt-out information.

This has been a big year for stories about women in tech, ranging from depressing tales of sexual harassment at startups to controversy over egg freezing and advice from a prominent CEO on *not* asking for a raise. The spotlight is shining on women in technology far more strongly than when I first covered this topic on the podcast in 2012. In this episode we focus on Silicon Valley, the tech capital of the world, and ask why it can be such a challenging place for women to work. My guests are Financial Times journalist Hannah Kuchler and tech worker Talia Fukuroe. See acast.com/privacy for privacy and opt-out information.

Russian and Saudi Arabian telecoms companies have been targetted by a sophisticated cyber snooping operation reminiscent of the Stuxnet worm that was developed by US and Israeli government hackers to target Iran. Fiona Symon talks to Sam Jones and Hannah Kuchler how the operation - known as the Regin malware - came to light and who is thought to be behind it. See acast.com/privacy for privacy and opt-out information.